A medicine that is used to treat leukaemia in cats is the latest hope in the fight against the coronavirus pandemic. Retromad1, a drug developed by Malaysian biotech firm Biovalence Technologies, has been proven to effectively fight a viral form of leukaemia and infectious peritonitis virus in cats.
Retromad1 was originally developed as a cure for herpes in humans, although it’s not currently approved for human use. Nevertheless, the drug has been shown to kill off FeCoV, a coronavirus that infects cats and there is considerable hope that it will have the same effect on COVID-19.
A Biovalence spokesperson said that several scientific papers showed that a specific mutation of Sars-CoV-2 bears similarity to how dengue, Ebola, FeCoV and HIV
Read more on dailystar.co.uk